Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label attachment file name title
tabling member	label

Search

1675274

registered interest
date	04/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Learning Support Fund: Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason students studying Masters of Pharmacy courses do not qualify for support from the NHS Learning Support Fund.
tabling member constituency	Liverpool, Riverside
tabling member printed	Kim Johnson
uin	5132
answer	answer is ministerial correction date of answer 06/12/2023 answer text <p>The Learning Support Fund (LSF) is available <ins class="ministerial">broadly</ins><del class="ministerial">only</del> to those courses which were eligible for the NHS Bursary prior to the 2017 reforms, and therefore, subjects such as pharmacy are outside of the scope of the LSF arrangements.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 06/12/2023 15:46:56 question first ministerially corrected 21/12/2023 14:14:55 answering member 4044 label Biography information for Andrew Stephenson previous answer version 5737 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	4824 label Biography information for Kim Johnson

1672053

registered interest
date	21/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of regional inequalities in access to molecular radiotherapy services; and what plans they have to reduce inequalities in access to those services.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL480
answer	answer is ministerial correction date of answer 05/12/2023 answer text <p>Based on information provided by National Health Service trusts, there are 38 providers of this service in England, spread across each of the seven NHS regions.</p><p>As part of the implementation process of the new standalone service specification for <ins class="ministerial">molecular radiotherapy</ins><del class="ministerial">magnetic resonance therapy</del> (MRT), which is expected from April 2024, work will be undertaken to confirm the nature and type of MRT services being provided by trusts and allow for access considerations to be taken into account.</p> answering member printed Lord Markham question first answered 05/12/2023 17:59:17 question first ministerially corrected 19/12/2023 13:27:07 answering member 4948 label Biography information for Lord Markham previous answer version 5569 answering member printed Lord Markham answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1654739

registered interest
date	20/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services: Cornwall
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding was recovered by NHS England from dental providers in Cornwall in 2021-22; and how much recovered funding was reallocated for the delivery of NHS dentistry in (i) Cornwall and (ii) St Ives, West Cornwall and Isles of Scilly.
tabling member constituency	St Ives
tabling member printed	Derek Thomas
uin	195463
answer	answer is ministerial correction date of answer 04/09/2023 answer text <p>Sums recovered from dentists in Cornwall for underperformance on contracts during 2021/2022 amounted to £4,562,496. The amount recovered is not available for reinvestment in the same financial year due to the calculations being finalised in the following financial year. Dental contracts are paid at the start of each financial year at 100% and so all contractors receive their full contract value to deliver activity in 2022/23.</p><p>£334,049.67 was recovered from under-performance of commissioned activity from the 2020/21 contract year and was reinvested for additional urgent dental care appointments <ins class="ministerial">that same year</ins><del class="ministerial">in 2021/22</del>.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 04/09/2023 12:21:03 question first ministerially corrected 12/09/2023 13:04:18 answering member 4679 label Biography information for Neil O'Brien previous answer version 90696 answering member constituency Harborough answering member printed Neil O'Brien answering member 4679 label Biography information for Neil O'Brien
tabling member	4532 label Biography information for Derek Thomas

1653025

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Brain: Tumours
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the Early Access to Medicines Scheme to ensure that brain tumour patients are able to access the most promising treatments.
tabling member printed	Lord Hunt of Kings Heath
uin	HL9326
answer	answer is ministerial correction date of answer 19/07/2023 answer text <p><del class="ministerial">We do not currently have a national mechanism to capture and report incidents of violence and aggression in the National Health Service. Data is held at a local level.</del></p><p> </p><p><del class="ministerial">At a national level, data on self-reported violent incidents is gathered through the NHS Staff Survey. Results from the 2022 NHS Staff Survey indicated that 14.7% of NHS staff have self-reported that they have experienced at least one incident of physical violence from patients, service users, relatives or other members of the public in the last 12 months.</del></p><p> </p><p><del class="ministerial">27.8% of NHS staff who completed the NHS Staff Survey experienced at least one incident of harassment, bullying or abuse in the last 12 months from patients or service users, their relatives or members of the public. This figure is similar to previous years’ NHS Staff Survey data.</del></p><p> </p><p><del class="ministerial">NHS England has commissioned a number of data insight workstreams to better understand the current landscape of statistics, data reporting and associated challenges. This includes a national review of all available data and intelligence sources, an analysis of the costs of violence to the health care system in England and a review of the impact on the safety and wellbeing of NHS staff.</del></p><p> </p><p><del class="ministerial">The Ministry of Justice collects data on prosecution, conviction and sentences for the offence of assault on an emergency worker, although it does not identify the type of emergency worker. This data is available in the Criminal Justice Statistics Quarterly and the Outcomes of Offence Tool and Offence Group Classification: Criminal Justice System Statistics Quarterly: December 2022, a copy of which is attached.</del></p><p><ins class="ministerial">The early access to medicines scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need.</ins></p><p><ins class="ministerial">Under the scheme, the Medicines and Healthcare products Regulatory Agency (MHRA) will give a scientific opinion on the benefit/risk balance of the medicine, based on the data available when the EAMS submission was made and the EAMS criteria. The MHRA will make an evaluation of products, including drugs such as for brain tumour treatments, once an application is received.</ins></p><p><ins class="ministerial">If we do receive an application, it is only made public where an EAMS Scientific Opinion (SO) is awarded. All EAMS SOs are published on the EAMS webpage. All drugs that have previously held an EAMS SO are also published on the EAMS webpage.</ins></p> answering member printed Lord Markham question first answered 19/07/2023 16:58:18 question first ministerially corrected 20/07/2023 11:30:24 answering member 4948 label Biography information for Lord Markham previous answer version 88876 answering member printed Lord Markham answering member 4948 label Biography information for Lord Markham attachment 1 file name criminal-justice-statistics-december-2022.pdf title Criminal Justice statistics
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1651487

registered interest
date	10/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Standards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the level of support available under the Pharmacy Access Scheme; and whether the criteria includes the (1) quality, (2) opening hours, and (3) range of provision, of existing pharmacies.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL9200
answer	answer is ministerial correction date of answer 19/07/2023 answer text <p><del class="ministerial">The early access to medicines scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need.</del></p><p><del class="ministerial">Under the scheme, the Medicines and Healthcare products Regulatory Agency (MHRA) will give a scientific opinion on the benefit/risk balance of the medicine, based on the data available when the EAMS submission was made and the EAMS criteria. The MHRA will make an evaluation of products, including drugs such as for brain tumour treatments, once an application is received.</del></p><p><del class="ministerial">If we do receive an application, it is only made public where an EAMS Scientific Opinion (SO) is awarded. All EAMS SOs are published on the EAMS webpage. All drugs that have previously held an EAMS SO are also published on the EAMS webpage.</del></p><p><ins class="ministerial">The Pharmacy Access Scheme provides additional funding to pharmacies where the next nearest pharmacy is more than a 20-minute walk away. This is calculated as a 0.8-mile walking distance in areas of high deprivation and 1 mile in other areas. In 2021, we agreed updated eligibility criteria and an updated payment model with Community Pharmacy England. To be eligible for the payment, pharmacies must deliver the Community Pharmacist Consultation Service. Quality and opening hours are not included in the eligibility criteria.</ins></p><p> </p><p> </p> answering member printed Lord Markham question first answered 19/07/2023 15:05:50 question first ministerially corrected 20/07/2023 15:18:01 answering member 4948 label Biography information for Lord Markham previous answer version 88780 answering member printed Lord Markham answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1650136

registered interest
date	04/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Processed Food
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what discussions they are having with (1) UK medical professionals and scientists, and (2) international partners, about (a) developing, and (b) agreeing, internationally recognised definitions of ultra-processed food.
tabling member printed	Baroness Suttie
uin	HL9040
answer	answer is ministerial correction date of answer 10/07/2023 answer text <p><del class="ministerial">The Government has no plans.</del></p><p><ins class="ministerial">The Scientific Advisory Committee on Nutrition (SACN) is currently carrying out a scoping review of the evidence on processed foods and health and aims to publish its initial assessment in the summer of 2023. SACN’s scoping review will make a number of research recommendations in this area. This review will also include evaluating existing classifications of processed foods, including ultra-processed foods and the NOVA classification.</ins></p><p><ins class="ministerial">SACN is a committee of the Office for Health Improvement and Disparities (OHID) and provides independent scientific advice and risk assessments on nutrition and related health issues. Members of SACN are appointed as independent scientific experts in their field. We are not aware of any plans to agree a definition internationally.</ins></p><p><ins class="ministerial">The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health including ultra-processed foods. The usual practice of the NIHR is not to ring-fence funds for expenditure on particular topics.</ins></p> answering member printed Lord Markham question first answered 10/07/2023 16:22:27 question first ministerially corrected 13/07/2023 14:43:31 answering member 4948 label Biography information for Lord Markham previous answer version 86576 answering member printed Lord Bethell answering member 4708
tabling member	4298 label Biography information for Baroness Suttie

1650137

registered interest
date	04/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Processed Food
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what plans they have to carry out research into the impact of ultra-processed foods on public health outcomes.
tabling member printed	Baroness Suttie
uin	HL9041
answer	answer is ministerial correction date of answer 10/07/2023 answer text <p><del class="ministerial">The Government has no plans.</del></p><p><ins class="ministerial">The Scientific Advisory Committee on Nutrition (SACN) is currently carrying out a scoping review of the evidence on processed foods and health and aims to publish its initial assessment in the summer of 2023. SACN’s scoping review will make a number of research recommendations in this area. This review will also include evaluating existing classifications of processed foods, including ultra-processed foods and the NOVA classification.</ins></p><p><ins class="ministerial">SACN is a committee of the Office for Health Improvement and Disparities (OHID) and provides independent scientific advice and risk assessments on nutrition and related health issues. Members of SACN are appointed as independent scientific experts in their field. We are not aware of any plans to agree a definition internationally.</ins></p><p><ins class="ministerial">The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health including ultra-processed foods. The usual practice of the NIHR is not to ring-fence funds for expenditure on particular topics.</ins></p> answering member printed Lord Markham question first answered 10/07/2023 16:22:27 question first ministerially corrected 20/07/2023 15:18:27 answering member 4948 label Biography information for Lord Markham previous answer version 86577 answering member printed Lord Bethell answering member 4708
tabling member	4298 label Biography information for Baroness Suttie

1649604

registered interest
date	03/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the percentage of seasonal flu vaccinations which can be delivered by (a) Community Pharmacies, (b) General Practice, (c) other providers.
tabling member constituency	Knowsley
tabling member printed	Sir George Howarth
uin	192008
answer	answer is ministerial correction date of answer 11/07/2023 answer text <p>NHS providers determine how many seasonal flu vaccines to buy each year based on their local populations, eligible cohorts and uptake ambitions for the NHS programme as outlined in the annual flu system letter. The letter, published on the 25 May 2023, is based on the advice of the Joint Committee on Vaccination and Immunisation (JCVI) who review the latest evidence on flu vaccines and advise on the type of vaccine to be offered to different age groups and on which vaccines should be prioritised for various at-risk groups.</p><p>General Practitioners and community pharmacists are responsible for ordering their own flu vaccines for the adult population from suppliers. These are then used to deliver the national flu vaccination programme, with deliveries phased through the season to help mitigate against risks of wastage, cold chain failure and to adequately cover the peaks and flows of local demand. In addition, Hospital Trusts are commissioned at local discretion, to further support delivery of the national flu vaccination programme, for example to women who are pregnant, long stay in-patients and those accessing outpatients' services.</p><p>School Age Immunisation Services (SAIS) are commissioned regionally to deliver the school aged influenza programme in line with the annual flu system letter and amendment published on the July 3, 2023. The school age programme for 2023/24 includes primary school aged children from Reception to Year 6 and secondary school-aged children in Years 7, 8, 9, 10 and 11. Vaccines for the children’s programme are procured nationally with SAIS</p><p><del class="ministerial">TARGET DATE 11/07/2023</del></p><p>providers responsible for drawing down their own vaccines according to their schedules, capacity and demand, with deliveries phased through the season to help mitigate against risks of wastage and cold chain failure.</p><p>For in detail seasonal influenza percentage uptake delivered by (a) Community Pharmacies, (b) General Practice, (c) other providers please see page 41 and 42 of the following link: <del class="ministerial">Seasonal influenza vaccine uptake in GP patients: winter season 2022 to 2023 (publishing.service.gov.uk)</del></p><p><ins class="ministerial"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1164871/GP-patients-flu-annual-report-2022-2023.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1164871/GP-patients-flu-annual-report-2022-2023.pdf</a></ins></p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 11/07/2023 16:13:38 question first ministerially corrected 12/07/2023 08:23:43 answering member 4492 label Biography information for Maria Caulfield previous answer version 87011 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	481 label Biography information for Sir George Howarth

1648716

registered interest
date	28/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Screening: Age
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what are the age limits on each of the NHS screening programmes and the justification for each limit.
tabling member printed	Lord Hunt of Kings Heath
uin	HL8877
answer	answer is ministerial correction date of answer 12/07/2023 answer text <p>All National screening programmes are introduced based on recommendations made by the UK National Screening Committee (UK NSC). The UK NSC assesses and evaluates the evidence to offer screening when it will offer more good than harm. Screening age ranges are selected based on the range where the evidence supports that balance.</p><p>The National Health Service breast screening programme invites eligible women to be screened every three years from the age of 50 up to their 71st birthday.</p><p>The NHS bowel screening programme invited men and women every two years from ages 60 to 74 years old. The programme is expanding to make it available to everyone aged 50 to 59 years old. This is happening gradually over four years and started in April 2021.</p><p>The NHS cervical screening programme invites people with a cervix between the ages of 25 and 49 for screening every three years, whilst people aged 50 to 64 receive an invitation every five years.</p><p>The NHS abdominal aortic aneurysm screening programme offers men a screening the year they turn 65.</p><p>The NHS diabetic eye screening programme is offered to anyone with diabetes who is 12 years old or over. Those eligible are invited for an annual screening.</p><p>The NHS targeted lung cancer screening programme that has been recently announced will invite people aged 55 to 74 identified as being at high risk of lung cancer for screening.</p><p>For antenatal screening programmes, pregnant women are invited early for screening once the pregnancy has been confirmed. This includes the NHS foetal anomaly screening programme and NHS infectious diseases in pregnancy.</p><p><ins class="ministerial"> <p><ins class="ministerial">Screening for newborns is also offered early at a time when conditions can be detected and where early treatment can improve the baby’s health and prevent severe disability or even death. Newborn screening programmes include the NHS newborn blood spot screening programme, the NHS newborn hearing screening programme, the NHS newborn and infant physical examination screening programme and the NHS sickle cell and thalassaemia screening programme.</ins></p></ins></p> answering member printed Lord Markham question first answered 12/07/2023 13:22:33 question first ministerially corrected 20/07/2023 15:18:13 answering member 4948 label Biography information for Lord Markham previous answer version 87138 answering member printed Lord Markham answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1644491

registered interest
date	13/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Integrated Care boards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what is their policy justification for deciding not to define an integrated care board as a “relevant body” in regulation 2 of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the effect that a range of patient rights formerly imposed on clinical commissioning groups are not now imposed on integrated care boards.
tabling member printed	Lord Hunt of Kings Heath
uin	HL8440
answer	answer is ministerial correction date of answer 27/06/2023 answer text <p><del class="ministerial">‘The National Health Service (Integrated Care Boards: Responsibilities) Regulations 2022’</del><ins class="ministerial"> The Health and Care Act 2022 (Consequential and Related Amendments and Transitional Provisions) Regulations 2022 SI/634</ins> has made consequential amendments to regulation 2 of the NHS Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, replacing references to Clinical Commissioning Groups with integrated care boards (ICBs). ICBs are now the statutory bodies responsible for patient rights.</p> answering member printed Lord Markham question first answered 27/06/2023 16:18:31 question first ministerially corrected 26/07/2023 13:28:18 answering member 4948 label Biography information for Lord Markham previous answer version 84191 answering member printed Lord Markham answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath